1. Dunstan, D.W., et al.: The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity, and lifestyle study. Diabetes Care 25, 829–834 (2002)
2. Rizvi, A.A.: Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach. South. Med. J. 97, 1008–1027 (2004)
3. Vaseem, A., Sethi, B., Kelwade, J., Ali, M.: SGLT2 inhibitor and DPP4 inhibitor co-administration in Type 2 diabetes—Are we near the “Promised Land”? Res. Rev. J. Pharmacol. Toxicol. Stud. 4, 6–11 (2016)
4. Wild, S., et al.: Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053 (2004)
5. International Diabetes Federation 2012, 5th edn. The Global Burden